General conclusions of the first clinical trials … *
renal alterations1 < <<* <
auditory alterations2 = = <<*
* highly significant by repeated variance analysis
2 high tone (10-18 kHz audiometry)
- Tulkens, Clerckc-Braune, et al. Safety and efficacy of aminoglycosides once-a-day: experimental data and randomized, controlled evaluation in patients suffering from pelvic inflammatory disease. J Drug Devel (1988) 1:71-82
- Van der Auwera Pet al., Pharmacodynamic parameters and toxicity of netilmicin (6 mg/kg.day) given once daily or in three divided doses to cancer patients with urinary tract infection., Antimicrob Agents Chemother (1991) 35:640-647
- Tulkens PM. Pharmacokinetic and toxicological evaluation of the once-daily regimen versus conventional schedules of netilmicin and amikacin. J. Antimicrob Chemother (1991) 27:49-61.